Canada Varicose Vein Treatment Devices Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Sclerotherapy), By End Use (Ambulatory Care Unit, Hospitals, Vein Clinics), By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Canada Varicose Vein Treatment Devices Market Growth & Trends
The Canada varicose vein treatment devices market size is expected to reach USD 77 million by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as pregnancy, sedentary lifestyle, obesity, and physical activities like standing for longer durations is expected to drive the market growth.
Hypertension is one of the main risk factors for varicose veins. In Canada, conditions like hypertension are rising, with 22% of adults having hypertension issues. Furthermore, the aging population is increasing significantly in Canada. With a rise in the geriatric population, cases of varicose veins are anticipated to increase as they are at a higher risk. Overall, 26% of adults in Canada have varicose veins as per the Canadian Society of Vascular Surgery, signifying high disease prevalence, thereby favoring the market growth.
However, the COVID-19 pandemic has negatively impacted the market as all non-urgent elective procedures, including varicose veins treatment surgeries, was postponed. Manufacturers operating in the market witnessed a decline in their revenues. The public healthcare system of Canada emphasizes more on conservative management of varicose veins rather than surgical procedures.
Canada Varicose Vein Treatment Devices Market Report Highlights
Canada Varicose Vein Treatment Devices Market Growth & Trends
The Canada varicose vein treatment devices market size is expected to reach USD 77 million by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. High prevalence of varicose veins due to risk factors, such as pregnancy, sedentary lifestyle, obesity, and physical activities like standing for longer durations is expected to drive the market growth.
Hypertension is one of the main risk factors for varicose veins. In Canada, conditions like hypertension are rising, with 22% of adults having hypertension issues. Furthermore, the aging population is increasing significantly in Canada. With a rise in the geriatric population, cases of varicose veins are anticipated to increase as they are at a higher risk. Overall, 26% of adults in Canada have varicose veins as per the Canadian Society of Vascular Surgery, signifying high disease prevalence, thereby favoring the market growth.
However, the COVID-19 pandemic has negatively impacted the market as all non-urgent elective procedures, including varicose veins treatment surgeries, was postponed. Manufacturers operating in the market witnessed a decline in their revenues. The public healthcare system of Canada emphasizes more on conservative management of varicose veins rather than surgical procedures.
Canada Varicose Vein Treatment Devices Market Report Highlights
- Canada has been witnessing a surge in the number of varicose veins cases in recent years
- According to the Canadian Society of Vascular Surgery, around 50% of people with varicose veins are aged 50 years and above
- Overall, 3.7 million people in Canada suffer from varicose veins and women are at a higher risk than men
- The sclerotherapy type segment accounted for the largest market share in 2020
- The growth is credited to the high adoption of this treatment due to the advantages, such as no need for anesthesia, no scarring, simple follow-up treatments, and no need for hospital admission
- The endovenous ablation segment is anticipated to witness the fastest CAGR over the forecast period as this treatment is preferred over conventional procedures, such as surgical stripping and ligation
- The hospitals end-use segment held a major share of the market in 2020 owing to the well-established healthcare infrastructure in Canada
- Product development, supply agreements with hospitals & clinics, and acquisitions are some of the strategic initiatives being undertaken by key market players to gain a higher market share
CHAPTER 1 REPORT SCOPE AND OBJECTIVES
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective
1.9.2 Objective
1.9.3 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 End Use
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Fetal and Neonatal Care Equipment Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing prevalence of varicose veins
3.2.1.2 Increasing demand for minimally invasive surgeries
3.2.2 Market Restraint Analysis
3.2.2.1 Low awareness about varicose vein treatment
3.2.2.2 Adverse effects of varicose vein procedures & lack of skilled professional
3.3 Business Environment Analysis Tools
3.3.1 Pestle Analysis
3.3.1.1 Political & legal
3.3.1.2 Economic & Social
3.3.1.3 Social
3.3.1.4 Technological
3.3.2 Porter’s Five Forces Analysis
3.3.2.1 Threat of new entrants: high
3.3.2.2 Bargaining power of buyers: high
3.3.2.3 Competitive rivalry: high
3.3.2.4 Threat of substitutes: moderate
3.3.2.5 Bargaining power of suppliers: moderate
3.4 Penetration & Growth Prospect Mapping
3.5 Impact of COVID-19: Qualitative Analysis
3.6 Reimbursement Scenario
3.7 Pricing Analysis
3.7.1 Average Cost Of Devices
3.7.2 Average Cost Of Procedures
CHAPTER 4 CANADA VARICOSE VEINS TREATMENT DEVICES MARKET: TYPE ANALYSIS
4.1 Canada Varicose Veins Treatment Devices Type Market Share Analysis, 2020 & 2028
4.2 Canada Varicose Veins Treatment Devices Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Type Segment
4.3.1 Endovenous Ablation
4.3.1.1 Endovenous ablation market, 2016 - 2028 (USD Million)
4.3.1.2 Endovenous laser ablation
4.3.1.2.1 Endovenous laser ablation market, 2016 - 2028 (USD Million)
4.3.1.3 Radiofrequency Ablation
4.3.1.3.1 Radiofrequency ablation market, 2016 - 2028 (USD Million)
4.3.2 Sclerotherapy
4.3.2.1 Sclerotherapy market, 2016 - 2028 (USD Million)
4.3.3 Surgical Ligation And Stripping
4.3.3.1 Surgical ligation and stripping market, 2016 - 2028 (USD Million)
CHAPTER 5 CANADA VARICOSE VEINS TREATMENT DEVICES MARKET: END USE ANALYSIS
5.1 Canada Varicose Veins Treatment Devices End Use Market Share Analysis, 2020 & 2028
5.2 Canada Varicose Veins Treatment Devices End Use Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the End Use Segment
5.3.1 Ambulatory Care Unit
5.3.1.1 Ambulatory care unit market, 2016 - 2028 (USD Million)
5.3.2 Vein Clinics
5.3.2.1 Vein clinics market, 2016 - 2028 (USD Million)
5.3.3 Hospitals
5.3.3.1 Hospitals market, 2016 - 2028 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.3 Company Market Position Analysis, 2020
6.4 Company Profiles
6.4.1 ANGIODYNAMICS
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 SWOT analysis
6.4.2 MEDTRONIC
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.2.5 SWOT analysis
6.4.3 TELEFLEX INCORPORATED
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.3.5 SWOT analysis
6.4.4 SCITON, INC.
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.5 BIOLITEC AG
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.6 DORNIER MEDTECH
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.7 MERIT MEDICAL SYSTEMS
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Product benchmarking
6.4.7.4 Strategic initiatives
6.4.7.5 SWOT analysis
6.4.8 ALMA LASERS
6.4.8.1 Company overview
6.4.8.2 Financial performance
6.4.8.3 Product benchmarking
6.4.9 BOSTON SCIENTIFIC CORPORATION
6.4.9.1 Company overview
6.4.9.2 Financial performance
6.4.9.3 Product benchmarking
6.4.9.4 Strategic initiatives
6.4.9.5 SWOT analysis
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective
1.9.2 Objective
1.9.3 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Type
2.2.2 End Use
2.3 Competitive Insights
CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Fetal and Neonatal Care Equipment Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing prevalence of varicose veins
3.2.1.2 Increasing demand for minimally invasive surgeries
3.2.2 Market Restraint Analysis
3.2.2.1 Low awareness about varicose vein treatment
3.2.2.2 Adverse effects of varicose vein procedures & lack of skilled professional
3.3 Business Environment Analysis Tools
3.3.1 Pestle Analysis
3.3.1.1 Political & legal
3.3.1.2 Economic & Social
3.3.1.3 Social
3.3.1.4 Technological
3.3.2 Porter’s Five Forces Analysis
3.3.2.1 Threat of new entrants: high
3.3.2.2 Bargaining power of buyers: high
3.3.2.3 Competitive rivalry: high
3.3.2.4 Threat of substitutes: moderate
3.3.2.5 Bargaining power of suppliers: moderate
3.4 Penetration & Growth Prospect Mapping
3.5 Impact of COVID-19: Qualitative Analysis
3.6 Reimbursement Scenario
3.7 Pricing Analysis
3.7.1 Average Cost Of Devices
3.7.2 Average Cost Of Procedures
CHAPTER 4 CANADA VARICOSE VEINS TREATMENT DEVICES MARKET: TYPE ANALYSIS
4.1 Canada Varicose Veins Treatment Devices Type Market Share Analysis, 2020 & 2028
4.2 Canada Varicose Veins Treatment Devices Type Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the Type Segment
4.3.1 Endovenous Ablation
4.3.1.1 Endovenous ablation market, 2016 - 2028 (USD Million)
4.3.1.2 Endovenous laser ablation
4.3.1.2.1 Endovenous laser ablation market, 2016 - 2028 (USD Million)
4.3.1.3 Radiofrequency Ablation
4.3.1.3.1 Radiofrequency ablation market, 2016 - 2028 (USD Million)
4.3.2 Sclerotherapy
4.3.2.1 Sclerotherapy market, 2016 - 2028 (USD Million)
4.3.3 Surgical Ligation And Stripping
4.3.3.1 Surgical ligation and stripping market, 2016 - 2028 (USD Million)
CHAPTER 5 CANADA VARICOSE VEINS TREATMENT DEVICES MARKET: END USE ANALYSIS
5.1 Canada Varicose Veins Treatment Devices End Use Market Share Analysis, 2020 & 2028
5.2 Canada Varicose Veins Treatment Devices End Use Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analysis, 2016 to 2028 for the End Use Segment
5.3.1 Ambulatory Care Unit
5.3.1.1 Ambulatory care unit market, 2016 - 2028 (USD Million)
5.3.2 Vein Clinics
5.3.2.1 Vein clinics market, 2016 - 2028 (USD Million)
5.3.3 Hospitals
5.3.3.1 Hospitals market, 2016 - 2028 (USD Million)
CHAPTER 6 COMPETITIVE LANDSCAPE
6.1 Recent Developments & Impact Analysis, By Key Market Participants
6.2 Company/ Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
6.3 Company Market Position Analysis, 2020
6.4 Company Profiles
6.4.1 ANGIODYNAMICS
6.4.1.1 Company overview
6.4.1.2 Financial performance
6.4.1.3 Product benchmarking
6.4.1.4 SWOT analysis
6.4.2 MEDTRONIC
6.4.2.1 Company overview
6.4.2.2 Financial performance
6.4.2.3 Product benchmarking
6.4.2.4 Strategic initiatives
6.4.2.5 SWOT analysis
6.4.3 TELEFLEX INCORPORATED
6.4.3.1 Company overview
6.4.3.2 Financial performance
6.4.3.3 Product benchmarking
6.4.3.4 Strategic initiatives
6.4.3.5 SWOT analysis
6.4.4 SCITON, INC.
6.4.4.1 Company overview
6.4.4.2 Financial performance
6.4.4.3 Product benchmarking
6.4.5 BIOLITEC AG
6.4.5.1 Company overview
6.4.5.2 Financial performance
6.4.5.3 Product benchmarking
6.4.5.4 Strategic initiatives
6.4.6 DORNIER MEDTECH
6.4.6.1 Company overview
6.4.6.2 Financial performance
6.4.6.3 Product benchmarking
6.4.7 MERIT MEDICAL SYSTEMS
6.4.7.1 Company overview
6.4.7.2 Financial performance
6.4.7.3 Product benchmarking
6.4.7.4 Strategic initiatives
6.4.7.5 SWOT analysis
6.4.8 ALMA LASERS
6.4.8.1 Company overview
6.4.8.2 Financial performance
6.4.8.3 Product benchmarking
6.4.9 BOSTON SCIENTIFIC CORPORATION
6.4.9.1 Company overview
6.4.9.2 Financial performance
6.4.9.3 Product benchmarking
6.4.9.4 Strategic initiatives
6.4.9.5 SWOT analysis
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Average cost of devices
TABLE 4 Average cost of procedures
TABLE 5 Canada varicose vein treatment devices market, by type, 2016 - 2028 (USD Million)
TABLE 6 Canada endovenous ablation devices market, by type, 2016 - 2028 (USD Million)
TABLE 7 Canada varicose vein treatment devices market, by end use, 2016 - 2028 (USD Million)
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 Average cost of devices
TABLE 4 Average cost of procedures
TABLE 5 Canada varicose vein treatment devices market, by type, 2016 - 2028 (USD Million)
TABLE 6 Canada endovenous ablation devices market, by type, 2016 - 2028 (USD Million)
TABLE 7 Canada varicose vein treatment devices market, by end use, 2016 - 2028 (USD Million)
LIST OF FIGURES
FIG. 1 Canada varicose veins treatment devices market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2020 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Canada varicose veins treatment devices type market share analysis, 2020 & 2028 (USD Million)
FIG. 15 Canada varicose veins treatment devices type market: Segment dashboard
FIG. 16 Endovenous ablation market, 2016 - 2028 (USD Million)
FIG. 17 Endovenous laser ablation market, 2016 - 2028 (USD Million)
FIG. 18 Radiofrequency ablation market, 2016 - 2028 (USD Million)
FIG. 19 Sclerotherapy market, 2016 - 2028 (USD Million)
FIG. 20 Surgical ligation and stripping market, 2016 - 2028 (USD Million)
FIG. 21 Canada varicose veins treatment devices end use market share analysis, 2020 & 2028 (USD Million)
FIG. 22 Canada varicose veins treatment devices end use market: Segment dashboard
FIG. 23 Ambulatory care unit market, 2016 - 2028 (USD Million)
FIG. 24 Vein clinics market, 2016 - 2028 (USD Million)
FIG. 25 Hospitals market, 2016 - 2028 (USD Million)
FIG. 26 Impact analysis by key market participants
FIG. 27 Strategy framework / Competition categorization
FIG. 28 Company market position analysis
FIG. 1 Canada varicose veins treatment devices market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Market outlook, 2020 (USD Million)
FIG. 10 Market trends & outlook
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 Canada varicose veins treatment devices type market share analysis, 2020 & 2028 (USD Million)
FIG. 15 Canada varicose veins treatment devices type market: Segment dashboard
FIG. 16 Endovenous ablation market, 2016 - 2028 (USD Million)
FIG. 17 Endovenous laser ablation market, 2016 - 2028 (USD Million)
FIG. 18 Radiofrequency ablation market, 2016 - 2028 (USD Million)
FIG. 19 Sclerotherapy market, 2016 - 2028 (USD Million)
FIG. 20 Surgical ligation and stripping market, 2016 - 2028 (USD Million)
FIG. 21 Canada varicose veins treatment devices end use market share analysis, 2020 & 2028 (USD Million)
FIG. 22 Canada varicose veins treatment devices end use market: Segment dashboard
FIG. 23 Ambulatory care unit market, 2016 - 2028 (USD Million)
FIG. 24 Vein clinics market, 2016 - 2028 (USD Million)
FIG. 25 Hospitals market, 2016 - 2028 (USD Million)
FIG. 26 Impact analysis by key market participants
FIG. 27 Strategy framework / Competition categorization
FIG. 28 Company market position analysis
